CLINICAL_TRIALS
trial_result
· 2020-11-19
Clinical Trial Update: Long-term Study of DSP-5423P in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 long-term study of DSP-5423P in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2020-11-19